The Oncology Institute, Inc. (NASDAQ:TOIIW) Short Interest Update

The Oncology Institute, Inc. (NASDAQ:TOIIWGet Free Report) was the target of a large decline in short interest in September. As of September 15th, there was short interest totalling 2,700 shares, a decline of 22.9% from the August 31st total of 3,500 shares. Based on an average daily volume of 9,600 shares, the days-to-cover ratio is currently 0.3 days.

Oncology Institute Price Performance

Shares of NASDAQ:TOIIW remained flat at $0.02 during midday trading on Friday. 5,976 shares of the stock traded hands, compared to its average volume of 21,618. Oncology Institute has a one year low of $0.01 and a one year high of $0.37. The business’s 50 day moving average price is $0.02 and its 200 day moving average price is $0.08.

Oncology Institute Company Profile

(Get Free Report)

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.

Read More

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.